Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics

Lignende værker

• Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017
  af: Vijay, Aishwarya, et al.
  Udgivet: (2019)
• Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015
  af: Egilman, Alexander C., et al.
  Udgivet: (2018)
• The backlash against bioequivalence and the interchangeability of brand-name and generic drugs
  af: Kesselheim, Aaron S.
  Udgivet: (2011)
• Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
  af: Liu, Patrick, et al.
  Udgivet: (2021)
• Brand and generic medications: Are they interchangeable?
  af: Al-Jazairi, Abdulrazaq S., et al.
  Udgivet: (2008)